NASDAQ:MRKR

Marker Therapeutics Stock News

etoro logo Buy MRKR
*Your capital is at risk
$1.45
+0.0300 (+2.11%)
At Close: Jun 03, 2026
Measures include extra money for deep cleaning and personal protective equipment
Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
Boris Johnson set to announce 10- and 11-year-olds will be first to attend when schools reopen
Boris Johnson says he wants primary schools back ‘as fast as we can’ as coronavirus pandemic continues
Moderna makes deal with Lonza to boost mRNA 1273 production. Marker receives orphan drug designation for AML drug. Jazz halts defibrotide trial on lack of posit
Toward the end of trading Thursday, the Dow traded down 1.42% to 24283.25 while the NASDAQ fell 0.81% to 8842.12. The S&P also fell, dropping 1.31% to 2,900.91. The U.S. is...
Midway through trading opening Thursday, the Dow traded down 1.02% to 24,384.04 while the NASDAQ fell 0.14% to 8,901.91. The S&P also fell, dropping 0.74% to 2,917.83. The U.S...

OSTK, AR among premarket gainers

01:20pm, Thursday, 30'th Apr 2020
LMP Automotive Holdings (NASDAQ:LMPX) +35%.AgEagle Aerial Systems (NYSEMKT:UAVS) +27%.Soligenix (NASDAQ:SNGX) +25% on positive SGX301 data.Secoo Holding (NASDAQ:SECO) +26% on share repurchase progra
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
Gainers Microsoft (NASDAQ: MSFT) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. Qualcomm (NASDAQ: QCOM) shares are trading...
Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
Gainers • Chimerix, Inc. (NASDAQ:CMRX) shares increased by 38.41% to $2.09 during Wednesday's pre-market session. • Accuray, Inc. (NASDAQ:ARAY) shares increased by...
Cytosorbents’ flagship product, CytoSorb can help interrupt the cytokine storm seen in COVID-19 patients with acute respiratory distress syndrome. Cytokine stor
Bryony Baynes, 58, head teacher at Kempsey Primary School in Worcester, said social distancing is "pretty much impossible" with young children. She said the thoughts of re-opening early was "giving me
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE